301 related articles for article (PubMed ID: 22035906)
21. Photodynamic diagnosis of non-muscle-invasive bladder cancer with hexaminolevulinate cystoscopy: a meta-analysis of detection and recurrence based on raw data.
Burger M; Grossman HB; Droller M; Schmidbauer J; Hermann G; Drăgoescu O; Ray E; Fradet Y; Karl A; Burgués JP; Witjes JA; Stenzl A; Jichlinski P; Jocham D
Eur Urol; 2013 Nov; 64(5):846-54. PubMed ID: 23602406
[TBL] [Abstract][Full Text] [Related]
22. Follow-up after surgical treatment of bladder cancer: a critical analysis of the literature.
Soukup V; Babjuk M; Bellmunt J; Dalbagni G; Giannarini G; Hakenberg OW; Herr H; Lechevallier E; Ribal MJ
Eur Urol; 2012 Aug; 62(2):290-302. PubMed ID: 22609313
[TBL] [Abstract][Full Text] [Related]
23. Hexylaminolaevulinate 'blue light' fluorescence cystoscopy in the investigation of clinically unconfirmed positive urine cytology.
Ray ER; Chatterton K; Khan MS; Thomas K; Chandra A; O'Brien TS
BJU Int; 2009 May; 103(10):1363-7. PubMed ID: 19076151
[TBL] [Abstract][Full Text] [Related]
24. Hexyl aminolevulinate-guided fluorescence cystoscopy in the diagnosis and follow-up of patients with non-muscle-invasive bladder cancer: a critical review of the current literature.
Rink M; Babjuk M; Catto JW; Jichlinski P; Shariat SF; Stenzl A; Stepp H; Zaak D; Witjes JA
Eur Urol; 2013 Oct; 64(4):624-38. PubMed ID: 23906669
[TBL] [Abstract][Full Text] [Related]
25. [Fluorescence guided endoscopy: improvement in the management of bladder cancer].
Uffer M; Jichlinski P
Rev Med Suisse; 2010 Dec; 6(274):2352-4. PubMed ID: 21290867
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of an orthotopic rat bladder urothelial cell carcinoma model by cystoscopy.
Hendricksen K; Molkenboer-Kuenen J; Oosterwijk E; Hulsbergen-van de Kaa CA; Witjes JA
BJU Int; 2008 Apr; 101(7):889-93. PubMed ID: 18201266
[TBL] [Abstract][Full Text] [Related]
27. Multicolor FISH (UroVysion) facilitates follow-up of patients with high-grade urothelial carcinoma of the bladder.
Fritsche HM; Burger M; Dietmaier W; Denzinger S; Bach E; Otto W; Doblinger M; Schwarz S; Buchner H; Hartmann A
Am J Clin Pathol; 2010 Oct; 134(4):597-603. PubMed ID: 20855641
[TBL] [Abstract][Full Text] [Related]
28. [Fluorescent endoscopy superior to white light endoscopy. Detecting cancers of the urinary bladder earlier].
Zaak D
MMW Fortschr Med; 2002 Mar; 144(13):24-6. PubMed ID: 12001582
[TBL] [Abstract][Full Text] [Related]
29. [Fluorescence diagnosis in patients with non-muscle invasive bladder cancer: results of a metaanalysis].
Kausch I; Sommerauer M; Montorsi F; Stenzl A; Jacqmin D; Jichlinski P; Jocham D; Ziegler A; Vonthein R
Aktuelle Urol; 2010 May; 41(3):171-7. PubMed ID: 20486035
[TBL] [Abstract][Full Text] [Related]
30. Can the burden of follow-up in low-grade noninvasive bladder cancer be reduced by photodynamic diagnosis, perioperative instillations, imaging, and urine markers?
Gakis G; Kruck S; Stenzl A
Curr Opin Urol; 2010 Sep; 20(5):388-92. PubMed ID: 20657287
[TBL] [Abstract][Full Text] [Related]
31. [ALA fluorescent diagnosis of bladder cancer].
Al'-Shukri SKh; Danil'chenko DI; Kënig F; Shnorr D
Urologiia; 2000; (5):48-50. PubMed ID: 11392226
[TBL] [Abstract][Full Text] [Related]
32. The FISH test for the diagnosis, surveillance, and prognosis of transitional cell carcinoma of the bladder.
Haddad FS
J Med Liban; 2008; 56(4):230-2. PubMed ID: 19115598
[TBL] [Abstract][Full Text] [Related]
33. Intravesical mitomycin C combined with hyperthermia for patients with T1G3 transitional cell carcinoma of the bladder.
Halachmi S; Moskovitz B; Maffezzini M; Conti G; Verweij F; Kedar D; Sandri SD; Nativ O; Colombo R
Urol Oncol; 2011; 29(3):259-64. PubMed ID: 19395285
[TBL] [Abstract][Full Text] [Related]
34. Does photodynamic transurethral resection of bladder tumour improve the outcome of initial T1 high-grade bladder cancer? A long-term follow-up of a randomized study.
Denzinger S; Wieland WF; Otto W; Filbeck T; Knuechel R; Burger M
BJU Int; 2008 Mar; 101(5):566-9. PubMed ID: 17986289
[TBL] [Abstract][Full Text] [Related]
35. A surveillance schedule for G1Ta bladder cancer allowing efficient use of check cystoscopy and safe discharge at 5 years based on a 25-year prospective database.
Mariappan P; Smith G
J Urol; 2005 Apr; 173(4):1108-11. PubMed ID: 15758711
[TBL] [Abstract][Full Text] [Related]
36. [Fluorescence diagnosis and photodynamic therapy in urology].
Stepp H; Waidelich R
Aktuelle Urol; 2007 Nov; 38(6):455-64. PubMed ID: 17987533
[TBL] [Abstract][Full Text] [Related]
37. Detection of early bladder cancer by 5-aminolevulinic acid induced porphyrin fluorescence.
Kriegmair M; Baumgartner R; Knüchel R; Stepp H; Hofstädter F; Hofstetter A
J Urol; 1996 Jan; 155(1):105-9; discussion 109-10. PubMed ID: 7490803
[TBL] [Abstract][Full Text] [Related]
38. [Hexvix induced fluorescence blue light cystoscopy--a new perspective in superficial bladder tumors diagnosis].
Geavlete B; Mulţescu R; Georgescu D; Geavlete P
Chirurgia (Bucur); 2008; 103(5):559-64. PubMed ID: 19260632
[TBL] [Abstract][Full Text] [Related]
39. A phase III, multicenter comparison of hexaminolevulinate fluorescence cystoscopy and white light cystoscopy for the detection of superficial papillary lesions in patients with bladder cancer.
Grossman HB; Gomella L; Fradet Y; Morales A; Presti J; Ritenour C; Nseyo U; Droller MJ;
J Urol; 2007 Jul; 178(1):62-7. PubMed ID: 17499283
[TBL] [Abstract][Full Text] [Related]
40. Cost-effectiveness of a modified care protocol substituting bladder tumor markers for cystoscopy for the followup of patients with transitional cell carcinoma of the bladder: a decision analytical approach.
Lotan Y; Roehrborn CG
J Urol; 2002 Jan; 167(1):75-9. PubMed ID: 11743279
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
